For more than 60 years Paragon Nordic has worked with product development and contract manufacturing of high quality products for our clients. Paragon Nordic always focus on function, quality and sustainability. Their production entities can be found in Vallentuna and Eket in Sweden, Skarnes in Norway and Vilnius in Lithuania.

Regenics collaborates with Paragon Nordic on formulation of the EPO patented  bioactive NTX® in a wound healing device.

 

 

Contact information:

 

Address:
Fabriksvägen 2
186 32 Vallentuna
Sverige

Website: www.paragonnordic.com/

Contact:
+46 8 511 888 00 | email : info@paragonnordic.com

Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.